Concepedia
Statistics
Publications
13
Citations
380
H-Index
11
Active since
2020
Affiliations
University of Michigan(Current)
Michigan Medicine
SK Life Science (United States)
Meilin Wang is an author at University of Michigan specializing in oncology, drug discovery, and molecular oncology.
Publications per year
2020–2025
A selective small-molecule STAT5 PROTAC degrader capable of achieving tumor regression in vivo
Atsunori Kaneshige, Longchuan Bai, Mi Wang et al. · Nature Chemical Biology · 2023 · 63 citations
Pharmacy, Medicinal Chemistry, Oncology +7
Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong <i>in vivo</i> Antitumor Activity
Lin Yang, Wenbin Tu, Liyue Huang et al. · Journal of Medicinal Chemistry · 2023 · 53 citations · Full text
Pharmacy, Oncology, Pharmacology +12
Discovery of Exceptionally Potent, Selective, and Efficacious PROTAC Degraders of CBP and p300 Proteins
J. Thomas, Mi Wang, Wei Jiang et al. · Journal of Medicinal Chemistry · 2023 · 50 citations · Full text
Pharmacy, Oncology, Pharmacology +13
Discovery of <b>ERD-3111</b> as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity
Zhixiang Chen, Biao Hu, Rohan Kalyan Rej et al. · Journal of Medicinal Chemistry · 2023 · 37 citations · Full text
Medicine, Oncology, Pharmacology +11
Discovery of CBPD-409 as a Highly Potent, Selective, and Orally Efficacious CBP/p300 PROTAC Degrader for the Treatment of Advanced Prostate Cancer
Zhixiang Chen, Mi Wang, Dimin Wu et al. · Journal of Medicinal Chemistry · 2024 · 35 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +15
1–5 of 13